Oct 17, 2017
This week, RealTalk MS is all about MS research.
We often hear about some of the important outcomes of MS research.
New drugs, like Ocrevus, are introduced. New information, like the
connection between gut bacteria and MS, is published. But how and
where does an MS research project get its start? How does it get
funded? How much multiple sclerosis research is actively taking
place today?
Jon's guest this week is Dr. Bruce Bebo,
Executive Vice President of Research at the National Multiple
Sclerosis Society. Since its inception, the National MS Society has
invested more than $900 million dollars in MS research. Jon and
Bruce discuss the key research priorities that the MS Society has
identified, and then take you on a step-by-step "behind the scenes"
look at exactly how the National MS Society evaluates and funds MS
research.
We'll also be talking about a new law in California that
represents a giant leap forward in creating transparency in
prescription drug prices. Over the past decade, the cost of
prescription drugs for treating MS has risen at a sharply
alarming rate. This new law may serve as a blueprint for other
states to follow.
And we'll give you a heads-up on an upcoming live webcast from
ECTRIMS in Paris (the largest conference in the world dedicated to
the understanding and treatment of MS), where you'll be
updated by a group of amazing researchers leading breakthrough
Progressive MS research.
We've got the news, views, interviews & breakthroughs that are
important to you. So...are you ready for RealTalk MS?